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Abstract

ARTERIAL WAVEFORM MEASUREMENT USING A
PIEZOELECTRIC SENSOR
By Ruizhi Zhang, B.S.

A thesis submitted in partial fulfillment of the requirements for the degree of
Master of Science at Virginia Commonwealth University

Virginia Commonwealth University, 2010

Director: Paul A. Wetzel, Ph.D.
Associate Professor, Department of Biomedical Engineering

This study aims to develop a new method to monitor peripheral arterial pulse
using a PVDF piezoelectric sensor. After comparing different locations of
sensor placement, a specific sensor wrap for the finger was developed. Its
composition, size, and location make it inexpensive and very convenient to
use. In order to monitor the effectiveness of the sensor at producing a reliable
pulse waveform, a monitoring system, including the PZT sensor, ECG, pulseoximeter, respiratory sensor, and accelerometer was setup.

viii

Signal analysis from the system helped discover that the PZT waveform is
relative to the 1st derivative of the artery pressure wave. Also, the system
helped discover that the first, second, and third peaks in PZT waveform
represent the pulse peak, inflection point, and dicrotic notch respectively. The
relationship between PZT wave and respiration was also analyzed, and,
consequently, an algorithm to derive respiratory rate directly from the PZT
waveform was developed. This algorithm gave a 96% estimating accuracy.
Another feature of the sensor is that by analyzing the relationship between
pulse peak amplitude and blood pressure change, temporal artery blood
pressure can be predicted during Valsalva maneuver.
PZT pulse wave monitoring offers a new type of pulse waveform which is
not yet fully understood. Future studies will lead to a more broadly applied use
of PZT sensors in cardiac monitoring applications.
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CHAPTER 1

Introduction
1.1 Historical Background
From antiquity, arterial pulse has been one of the most fundamental
measures in medicinal practice. Many cultures developed qualitative
interpretations of changes in the texture and strength of the arterial pulse
associated with a patient’s health status [1]. In traditional Chinese clinical
medicine, palpation has been used as one of the four basic diagnostic
methods for thousands of years. The graphic method of recording arterial
pulse, however, was not discovered until 19th century. The sphygmography
developed by Dr Frederick Akbar Mahomed provided a quantitative illustration
of the effects of medication on the arterial pulse; it also provided a picture of
the arterial waveform in hypertension and other diseases. Furthermore, these
were the first ever signals that displayed time-related changes in a
physiological parameter, which could then be recorded and compared with
signals at different times or in different subjects [2]. By the beginning of the
20th century, sphygmography was well established in medical practice, as
reported in medical journals and textbooks (Figure 1), and its ability to
describe the effects of aging on arterial degeneration was widely used by life
insurance

companies

for

estimation

1

of

risk

[2,3].

Unfortunately,

sphygmography lapsed with the development of the brachial cuff and the
auscultatory technique to produce the sphygmomanometer in the early 20th
century. This provided pressure measurements in terms of the height of a
column of mercury, where values of pressure were associated with the peak
(systolic pressure) and trough (diastolic pressure) of the arterial pressure
pulse.

Figure 1, Sphygmography in 1800s
The figures depict the evolution of sphygmography technology in the late 1800s to the early
1900s, before the advent of the modern sphygmomanometer. (a) Sphygmomanometry
instrument developed by Dr Mahomed in 1872 (Courtesy: University of Manchester Medical
School Museum, 2008); (b) Sphygmomanometry device developed by Dr Dudgeon and used
by Sir James MacKenzie in 1902 (Courtesy: Home´opathe International, 2001); and (c)
Sphygmograph with arterial waveform recorded by a pen-recorder developed by Dr Marley in
1914 (Courtesy: Letzte A¨ nderung: June 21, 2007 [3].

The conventional sphygmomanometric measurement of brachial cuff
systolic and diastolic has been widely used to quantify arterial blood pressure
associated with cardiovascular risks, as well as complications with many other
diseases, such as diabetes. However, it fails to provide the continuous
information of arterial pressure, which is highly related to the physical
properties of the elastic arteries, arterial stiffness, pulse wave velocity and
2

altered wave reflection as independent risk factors for cardiovascular disease.
Mahomed in 1874 was also the first person to recognize the difference
between pressure waves in central and peripheral arteries, while MacDonald’s
publication on blood flow in arteries and arterial mechanics explained this
phenomenon on the basis of wave reflection and introduced transfer functions
to characterize properties of vascular beds in the frequency domain [4]. Since
then, the advent of the microcomputer has allowed the discovery of noninvasive techniques for accurate pulse wave recording, which led the
development of pulse wave analysis.
1.2 Measurement Methods for Arterial Pressure and Pulse Wave
1.2.1 Sphygmomanometer
In 1896 Riva-Rocii invented the palpation method to measure systolic
pressure with a brachial cuff inflated to obliterate peripheral pulse. With this
technique, the cuff is gradually deflated until the peripheral pulse is again felt
at the radial artery [5]. The cuff pressure at which the pulse is initially felt is
the systolic pressure. The information required for estimation of diastolic
pressure became available with Korotkoff’s observation that sounds heard
through the stethoscope placed over the brachial artery change [6]. As the
pressure in the cuff falls, a “whooshing” or pounding sound, called the
Korotkoff sound is heard when blood flow first starts again in the artery. The
pressure at which this sound began is noted and recorded as the systolic
blood pressure. The cuff pressure is further released until the sound can no
longer be heard. This is recorded as the diastolic blood pressure [7]. A more
formal description of the phase of the Korotkoff sounds was employed by
Gedees, O’Brein and Fitzgerald, who divided the spectrum of the Korotkoff
3

sound into five different phases [8, 9]. These phases occur sequentially during
the cuff deflation and Phase I, IV and V are considered useful to estimate
systolic and diastolic pressure.
1.2.2 Applanation Tonometry
Since the technique of Applanation Tonometry was employed by Pressman
and Newgard to measure arterial pressure wave shapes in 1963, it has
become one of the most widely used type of transducer for accurate, noninvasive detection of the peripheral arterial pressure wave [10, 11]. Applying
applanation tonometry (see Figure 2) involves flattening a curved surface,
such that any wall tension is effectively reduced to zero and there is
transmission of all internal force to the external transducer [3,12]. In this case
for pulse wave acquisition, when the artery underlying the skin surface is
flattened using gentle pressure of the manometer, circumferential pressures
within that point of the artery are equalized and an accurate pressure
waveform can be recorded (Figure 2) [3]. Because this requires a rigid
support for the artery, the most accessible and suitable anatomic location is
the wrist, where the radial pulse can be readily palpated. The major sensor
types are the single sensor and an array of sensors. The single sensor is a
piezoresistive transducer with dimensions much smaller than the arterial
diameter at the end of a hand-held pencil-like stem. The array of sensors
contains sensors positioned over the radial artery where the optimum signal is
selected by computer algorithms [13, 14]. Accurate quantitative tonometry
cannot be achieved in practice because of the soft tissue which lies between
the skin and anterior wall of the artery, but measurements can be
approximated by a calibration process. Accurate quantitative tonometry also
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can also be used to monitor breathing, hypovolemia, anesthesia and other
circulatory conditions. Other studies also extend the use of the PPG waveform
to the detection of ventricular ejection times and pulse wave analysis, as well
as the quantification of vascular function [15, 16]. Allen has provided an
extensive review of PPG and its applications in physiological measurement
and clinical use [17].
1.2.4 Direct Blood Pressure Monitoring
Since 1733 when Stephen Hales first attached a vertical tube to an artery of a
horse and measured mean arterial pressure, the intra-arterial method has
been one of the most accurate ways to measure arterial blood pressure (BP).
Even today, it is widely used in critical care, operating rooms, and in these
patients with low cardiac output states when pulses may be poorly palpable
and Korotkoff sounds may be difficult to hear [18]. Invasive monitoring
provides a moment-to-moment picture and visual display of BP trends. During
direct BP monitoring, an artery is cannulated with a catheter, which is
connected to fluid-filled tubing and an electronic pressure transducer system.
Despite its accuracy, invasive vascular pressure monitoring can result in
complications such as thrombosis, infection, air embolism, bleeding,
arteriovenous fistulas, and pain [19]. Therefore, it is used mostly in patients
with severe conditions and as a standard reference when compared to other
non-invasive BP monitoring methods in scientific studies.
1.3 The Basis of Pulse Wave Analysis
1.3.1 Pulse Wave Features
The technique of non-invasive aortic pulse wave analysis, as used in most
commercial cardiac monitoring systems, depends on three parameters:
6

accurate recording of the peripheral pressure wave, its calibration against
brachial pressure, and generation of the ascending aortic pressure waveform
through the use of a generalized transfer function in a computerized process
[4]. As mentioned, understanding the different features of pulse waveform
between aorta and peripheral arteries is essential. The contour of the pulse
waveform at the aortic artery is determined by the pattern of ventricular
ejection and the elastic and geometric properties of the arterial tree [20]. In
the ascending aorta (Figure 3, left), the first inflection generally coincides with
the time of peak flow velocity (at pressure value of Pi), at approximately 30%
of the ejection duration [1, 21]. Systolic pressure (Ps) occurs after peak flow.
The ratio of the augmented component of pressure described as (Ps-Pi)/(Ps-Pd)
is defined as the augmentation index (AIx). Aix has been found to have a
significant heritability factor and shows changes with respect to age [1,22, 23,
24].

Figure 3, Peripheral and Central Pressure Waveform
Features of the radial pulse wave and corresponding central aortic pressure wave. Radial
pressure wave was recorded from a 50 year old male, BMI of 23.72 kg m−2, and central
pressure wave derived using an aortic-radial transfer function. MAP: mean pressure [1].
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The radial pulse is also characterized by a number of waveform features
(Figure 3). The minimum point in the pressure waveform corresponding to
diastolic pressure (Pd) is often equated to that in the aorta and together with
mean pressure is used as a calibration reference [1, 25, 26]. The first peak in
the waveform corresponds to systolic pressure (Ps) and is different than the
first peak of central pulse, with a large variation in the difference. An inflection
(Pi) occurs late in systole and is usually lower than Ps but may form a local
maximum higher than Ps in cases of high arterial stiffness, as seen with
advancing age [1, 27]. A local minimum near the end of systole, labeled as
the dichrotic notch, strongly correlates with the timing of the incisura obtained
from the aortic pressure pulse, and therefore corresponds to aortic valve
closure, and can be used to obtain systolic duration.
1.3.2 Transfer Function
Transfer functions are mathematical representations used to describe the
relationship between central and peripheral pressure. The intention of this
transfer function is to determine the central aortic pressure by means of
peripheral arterial pressure pulse wave shape, using sphygmomanometric
cuff measurements as calibration. A significant characteristic of the pressure
pulse is that it changes shape as it travels away from the heart. In large
arteries, mean pressure is essentially constant. Hence, shape changes are
such that the total waveform area over on one cardiac period is constant, and
this generally results in a change of pulse height [1]. These features were
documented by Kroeker and Wood in 1955 [28] using intra-arterial catheters
to record the pulse wave. After that, a simple tube model showing the change
in arterial pulse and pulse amplitude amplification due to elastic and
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geometric non-uniformity were studied by many researchers [1, 29, 30, 31,
32]. The study by Karamanoglu in 1993 formed the basis for the development
of a generalized transfer function, where it was proposed that the transfer
function could be applied to adults for the non-invasive estimation of central
aortic pressure [1, 33]. There have been other attempts at individualization
and development of group-specific functions [1, 34, 35] showing that
individual differences should be considered when applying a transfer function.
1.4 Objective of This Study
It is assumed that the pulse waveform signal contains much more information
than just systolic and diastolic blood pressure, and current major monitoring
methods such as applanation tonometry, photoplethysmography, and intraarterial measure all have deficiencies at some level. The objective of this
study is to develop a new pulse wave monitoring system using a PVDF
piezoelectric sensor and to compare the features of the obtained wave form to
that of a PPG. A further objective of this study is to find any correlation
between pulse waves and respiration using pulse wave analysis. Different
types of maneuvers are also monitored to determine waveform changes that
may correspond to physiological conditions.

9

CHAPTER 2

Material and Device Construction
2.1 Piezoelectric PVDF Sensor
Creating an acceptable sensor to monitor blood pressure is one of the most
important components of this study. An acceptable sensor is one that is
sensitive, reliable, non-toxic, and inexpensive. Of these factors, sensitivity is
of major concern given that the sensor must detect subtle changes through
the skin caused by the pulsation of the artery. While sensitivity is of vast
importance, the signal from the sensor also needs to be in a voltage large
enough to allow the user to differentiate between noise and the actual
measurement.
PVDF is a highly non-reactive and purely thermoplastic fluoropolymer. The
strong piezoelectricity of a PVDF was observed by Kawai in 1969 [36]. The
piezoelectric coefficient of the polarized thin films were reported to be as large
as 6-7 pC/N, which is 10 times larger than that observed in any other polymer
[37]. As pressure is applied to the PVDF sensor, the film of the sensor flexes
to generate an electric potential which is amplified, then acquired through a
data acquisition system and recorded by computer for later analysis. The
sensor is sensitive to mechanical strain which means it can monitor the
change of applied pressure but does not respond to a sustained or
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unchanged pressure. In this study, expansion of the blood vessel as blood
passes through the artery is captured by the sensor and then transformed into
an electrical signal. The electrical signal is displayed on the computer screen
and labeled as the piezoelectric transducer (PZT) pulse waveform. The PZT
pulse waveform is not like the traditional pulse waveform which represents
actual blood pressure over time. Instead, it represents the change in blood
pressure over time.
A commercially available piezoelectric adult snore sensor manufactured by
Dymedix Corporation (Shoreview, Minnesota) was initially used to evaluate
potential recording measurement locations throughout the body. At first, the
sensor was placed on radial, brachial and temporal arteries separately to test
the quality of signal waveform. One of the problems is that the sensor
required sustained pressure to maintain close contact with the arteries
through the skin and soft tissue. Manually pressing the sensor at the correct
spot often resulted in a better signal waveform. It was found however, the
human hand cannot maintain a stable pressure in a long term setting which
creates a greater opportunity for false readings. A stretch band was then used
to try to prevent this problem, since the band stretch pressure is evenly
dispersed and constant. Signal strength, however, is not as good as manually
pressing the sensor to the test location. Even though, pulse waves captured
on these spots were very helpful in initially observing this new type of pulse
waveform, in order to do more extensive things such as discover the
correlation between PZT pulse waves and respiration and predict head blood
pressure, a more reliable sensor needed to be created.
Considering that one of the major tasks of this project was to develop a
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method for long term monitoring of pulse wave, both a head band and arm
band were rendered uncomfortable and inconvenient. A much smaller sensor
on the finger seemed to be more suitable for this purpose. Unfortunately, the
adult snore sensor made by Dymedix Corporation could not be used to
accomplish this task since the padding was too stiff to curve and conform to
the curvature of the finger. Thus a more flexible sensor had to be developed.
Using the parts and materials provided by Dymedix Corporation, a new
sensor, more suitable for testing pulse from finger, was designed. The
materials include a roll of PVDF film, two conductor lead wire with oval tabs,
and a sheet of ARclad. ARclad is high-performance industrial pressuresensitive adhesive with good electrical conductivity. The PVDF film is like a
dual plate capacitor, so it had to be precisely with a very sharp pair of scissors
to avoid shorting out the two sides of the film. The sensitivity of PVDF film to
stress and or stretching is different along two directions. Cutting the film along
the poling direction provides 7 times better sensitivity in contrast to the other
direction (Dymedix documentation). A rectangle shape film was cut to a length
of 5cm and width of 1cm. The length of the longer side is about one-half to
two-thirds of the girth of the base segment of the finger. Therefore the film
could fully cover the artery area alongside the finger bone while still not
overlapping. Then, the supplied wire was affixed, using a small amount of
ARclad placed between the wire tab and the center of the short edge of the
metalized PVDF film sensor surface, on both sides. To avoid shorting out the
sensor, extreme care was exercised when preparing the custom made
sensors, particularly when applying the ARclad conductive adhesive paste for
attaching the electrodes to each side of the film. The entire sensor assembly
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2.3 Monitoring System with Other Physiological Measurements
To fully understand the PZT pulse waveform, comparisons with other existing
methods of cardiovascular monitoring were required. Based on the present
lab equipment, a 3-lead electrocardiography (ECG) equipment (Criticare
Systems, Walkasaukee, WI), and a pulse-oximeter were used during the tests
as

references.

The

analog

output

of

the

ECG

signal

and

photoplethysmography were connected to the Biopac as well as the PZT
signal, so that a comparison of the three waveforms could be recorded
simultaneously during each test. To measure breathing, a negative
temperature coefficient (NTC) type thermistor was used as a respiratory
monitor to record the respiration information which is relative to cardiovascular
system conditions [38]. An accelerometer was also placed on the same finger
as the piezoelectric sensor to record the movement of the testing spot as a
method to distinguish and/or eliminate the PZT pulse waveform noise caused
by unwanted movement of the body. Thus a monitoring system based on the
PZT pulse waveform accompanied by ECG, pulse-oximetry, respiratory chart
and accelerometer was developed as Figure 6 shows.
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in which the resistance varies with temperature. The relationship between
resistance and temperature in a NTC is indirectly proportional. In most cases,
room temperature is below body temperature which is 37 degrees Celsius.
During respiration, people inhale relatively cooler air and exhale relatively
warmer air, this temperature change will be captured by the thermistor then
translated to electrical signal to be recorded by Biopac system. The signal is a
reflection of respiration conditions with no time delay.
A Wheatstone bridge circuit was used to convert the resistance change of
the thermistor to voltage change which could be recorded by Biopac
acquisition system. Figure 7 shows the circuit diagram of the Wheatstone
bridge and amplifier. The bridge circuit was supplied by a 5 volts power supply.
R1, R2 had the same resistance of 9.8 kohm. Rx was set to a value similar to
the resistance of thermistor in normal room temperature. The output of the
bridge was measured between points A and B which were then differentially
with an AD-524 instrumentation amplifier with a gain of 10. Once there is a
resistance change on the thermistor, a voltage difference occurs between
point A and B. The signal was amplified and filtered then sent to the Biopac
system to be displayed as a respiration waveform.

Figure 7, Bridge Circuit and Amplifier
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Another method to monitor respiration taken into consideration was using a
CO2 sensor provided by Biopac System. The reason for using a thermistor
instead of the CO2 sensor was that the respiration waveform from the CO2
sensor has a fair amount of time delay compared to the PZT pulse wave,
pulse-oximetry and ECG signals which transmit form the body to the
acquisition system in no time. This is because the CO2 sensor is located in the
Biopac base and connects to patient’s mouth through a tube and it takes time
for the airflow to travel the length of a tube that is one meter in length. The
time delay would potentially cause problems in determining the relationship
between respiration and pulse wave.
2.3.2 Accelerometer
An ADXL203 chip was used in the project (Analog Devices, Norwood, MA). It
is a high precision, low power and dual-axis accelerometer with signal
conditioned voltage outputs. It can measure acceleration with a full-scale
range of ±1.7 g and it is sensitive to both dynamic and static acceleration [41].
In this experiment it was used to detect small finger movements which may or
may not be shown in the PZT waveform. The ADXL203 has provisions for
band limiting the XOUT and YOUT pins. Capacitors must be added at these pins
to implement low-pass filtering for anti-aliasing and noise reduction [41]. The
equation for 3 dB bandwidth is
F–3 dB = 1/(2π(32 kΩ) × C(X, Y))
Or more simply,
F–3 dB = 5 μF/C(X, Y)
Since the movement of the body appeared to be low, two 0.47 μF capacitors
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were used to limit the bandwidth of the accelerometers to less than 10 Hz. A
5 volt power supply was connected to the chip to run the internal amplifier and
the XOUT and YOUT pins were connected to Biopac system as shown in Figure
8.

Figure 8, Circuit Diagram of ADXL203

The accelerometer was taped on the tip of the same finger to which the
PZT sensor was attached. Since PZT was placed around the base segment of
the finger, the movement that affected the pulse wave the most was bending
the finger. When bending the favor, the tip of the finger moved the most which
gave

accelerometer

strongest

stimulation.

The

great

sensitivity

of

accelerometer could ensure the recognition of any noise in the PZT pulse
waveform which is cause by the movement of the finger.
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CHAPTER 3

Methods
3.1 Testing Spots
Piezoelectric sensors detect mechanical change of peripheral arteries during
pulsation through skin and soft tissue of the desired location. Anatomy
differences affect the PZT pulse waveform depending on where the sensor is
located on the body. Initially, locations were compared and contrasted to
determine which location produced the strongest and cleanest signal. There
are many locations on the human body at which arteries are close enough to
the skin to allow the pulsation to be detected with a piezoelectric sensor.
Digital arteries alongside the proximal phalanges of the hand, radial arteries at
the wrist, brachial arteries from the inside of elbow, superficial temporal
arteries from the temple, and a location just in front of the tragus were the five
chosen locations used to test the sensor.
Since the radial artery is commonly used to take pulse measurements, it
would be an ideal location to place the sensor. After being amplified 10 times,
the signal amplitude produced at the wrist is about 1.5 volts to 2.5 volts,
depending on the individual. However, a large amount of pressure is needed
to keep a signal. The radial artery is along the medial edge of the radius and
easily drops below the tendons of the wrist by way of any applied pressure or
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movement. Therefore it is a usual occurrence to lose the signal when
changing the angle of wrist joint and it was nearly impossible to detect a
viable pulse signal when bending the wrist toward the front side of forearm.
This eliminated the possibility of the wrist being a location for long-term
monitoring. The signal, however, was enhanced by manually pressing the
sensor to the wrist and since the wrist is one of the locations exhibiting the
strongest pulsation in the human body, it may still be a good place to measure
a short term pressure wave with the PZT sensor.
The Brachial artery on the inside of the elbow was the first spot to be
completely eliminated. Observation showed that people with thinner arms
could obtain a far better measurement on brachial arteries. This may be
because more muscle mass and/or thicker layers of adipose tissue prevent
the contact between arteries and the sensor.
The head has some benefits as test location for the PZT pulse
measurement. First, the superficial temporal arteries come up to the head
from the cheek to the temple, which contains less muscle and fat than other
places on the body no matter the individual. Thus, when doctors cannot obtain
a pulse in the arm of patients with obesity they nearly always go to their heads
to obtain pulse wave information. Additionally, trauma patients being
monitored on an ambulance or an ICU tend to move their heads far less than
any other part of the body and this may eliminate a vast amount of noise
created by movement of the sensor. A headband with padding on the site of
temple was used to affix the head sensor. The signal obtained from the
temple was clearer than the signal obtained from wrist and inner region of the
elbow.
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The signal from the site right in front of tragus is as clear as the one from
temple. However, a headband with padding did not work well at this location.
A headphone-like housing to hold the sensor may prove to be the best
solution for this location. Unfortunately, finding the right place to position the
sensor was not simple. If it were a simple task, it could be one of the best
locations for measuring the PZT pulse wave.

Figure 9, PZT Waveform from Different Spots
Form top: digital artery aside finger, superficial temporal artery in front of ear, brachial artery
in side of elbow, radial artery at the wrist and temporal artery from temple.

The sensors used in the descriptions above were obtained from the
commercial Dymedix Corporation adult snore sensors. The sensor pad was
placed flat on the surface of the skin because it was determined that bending
this sensor creates excessive noise. Figure 9 shows the comparison of the
pulse waveforms captured from the different locations on the body in the
same scale. The top waveform from the digital arteries aside finger is
recorded using self-made finger wrap sensor. As seen in the figure, the signal
obtained from the finger was significantly greater in amplitude when compared
to the other four sites. Moreover, the signal from finger is more reliable and
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easier to obtain in terms of ease of placement. It has a relatively strong
immunity to noise caused by body movement except for movement of the
tested finger. Thus the best locations for PZT pulse monitoring are the digital
arties along the side of the proximal phalanges. Table 1 shows a summary of
the advantages and disadvantages of the different testing locations.
Table 1, Comparison of Different Testing Locations

Location
Radial arteries at the wrist

Advantage
Artery is easy to find
Relatively high pulsation

Disadvantage
Signal easily get lost when
the wrist is moved

Brachial arteries from the

Largest pulsation point on some

Artery is very hard to find on

inside of elbow

individuals

some individuals

Superficial temporal arteries

Relatively clear signal

Finding the right testing spot

from the temple
Superficial temporal arteries

takes some time
Very clear signal

in front of the tragus
Digital arteries alongside the
proximal phalanges

Special device to maintain
the sensor contact is needed

Clearest and most reliable signal
Placing the sensor is very easy

Sensor must be created
manually

3.2 Experiential Procedure
3.2.1 Comparison of PZT and PPG waveform
PZT sensors do not record the real value of blood pressure; instead it records
the change in pressure. The first step to understand the PZT pulse wave is
comparing it to an existing, fully-understood, pulse monitoring method. In this
study, a finger pulse oximeter was used to record the PPG waveform at the tip
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of the same finger on which the PZT sensor was wrapped. ECG was also
recorded at the same time as a reference.
3.2.2 Testing the correlation between PZT waveform and respiration
Four volunteers were used to test the PZT sensor, pulse-oximeter and
breathe. During the test, subjects performed normal breaths, long deep
breaths, and practiced breathe holding in both the sitting and prone positions.
To ensure that all locations have the same correlation, the PZT sensor was
also placed on the wrist, elbow, and temple areas to record the PZT waveform
along with respiration monitoring.
3.2.3 Testing on temporal artery with different head vertical positions
An interesting phenomenon during the study was that the height of the peaks
in the PZT pulse waveform changed with the change of vertical distance
between testing spot and the horizontal level of heart. Therefore, a test was
created placing a sensor on the temple and the head was moved to different
vertical positions relative to the horizontal position of the heart. By defining
the position of the heart as zero, signals were recorded on each person with
their temporal artery at positions of 15, 25 and 36 cm above the heart.
3.2.4 Valsalva maneuver
A Valsalva maneuver is performed by a forcible exhalation against a closed
airway, usually done by closing one’s mouth and pinching one’s nose shut. It
is used in medical examinations as a test of cardiac function and autonomic
nervous control of the heart. Valsalva maneuvers can lead to a series of
physiological responses, mostly in the heart and cardiovascular systems and
can result in measurable changes in heart rate, blood pressure, and pulse
wave contour. Observation of a change of the PZT pulse waveform during
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Valsalva maneuver is helpful to define the features of it. Therefore a short
term and long term Valsalva maneuver tests with the PZT, pulse-ox, and ECG
monitoring was designed.
3.2.5 Long term monitoring with accelerometer
When monitoring pulse waves by way of PZT for long periods of time, body
movement affecting the PZT pulse waveform is inevitable. To more clearly
distinguish signal from artifact an accelerometer was introduced into the
system to monitor movement of the finger and compared to the artery
pulsation signal. Tested subjects were asked to casually sit with the PZT
sensor and accelerometer attached to one finger for 10 minutes or longer.
During the test, subjects were free to move their finger and/or arm. The PZT
pulse waveform and finger acceleration chart were recorded for future
analysis.
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CHPATER 4

Results and Analysis
4.1 The Character of PZT Pulse Waveform
According to an article discussing the relationship between wideband external
pulse (WEP) wave and intra-arterial pulse wave by Payne [41], the WEP wave
resembled the first derivative of the intra-arterial pressure pulse wave. The
WEP signal was recorded using a broad bandwidth piezoelectric sensor
located

over

the

brachial

artery,

under

the

distal

edge

of

a

sphygmomanometer cuff, which has the same features as the PZT pulse
waveform since they are both recording the artery pulsation using a
piezoelectric sensor.
Figure 10 shows a PZT pulse waveform recorded at the bottom segment of
middle finger and pulse oximeter waveform at the tip of the same finger. As
shown in Figure 10 a time gap between the peaks of the PZT sensor and
pulse oximeter sensors exists. The peak in the PZT waveform appears about
0.14 seconds earlier than the peak in the pulse oximeter waveform in the
same cardiac cycle, which indicates something about the nature of the two
signals. Pulse oximetry is a non-invasive method of monitoring the
oxygenation of a patient's hemoglobin which is a reflection of blood pressure.
PZT pulse waveform, on the other hand monitors the change of blood
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Figure 11, PZT and 1stt Derivative of
o SpO2 Wav
veform
Top: SpO2 wavefo
orm; Middle: 1st derivative
e of SpO2 wav
veform; Botto
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28

time less than 0.03 seconds. This means that the travel time of a pulse wave
form the bottom segment of finger (PZT location) to the finger tip (SpO2
location) should be less than 0.015 seconds by a simple a distance ratio.
Thus, the time shift in the peaks must be caused by the different type of pulse
wave recording methods. It is acceptable that these two methods of
measurement have a time difference as small as 0.08 seconds. Therefore, it
was believed reasonable to add a time shift to either of the pulse waveforms
to better analyze the correlation between the first derivative of SpO2
waveform and the PZT waveform.
As shown in Figure 11, SpO2 waves show a major peak, corresponding to
the maximum blood pressure and a small deflection on the down stroke of
waveform known as the dicrotic notch. The Dicrotic notch appears
immediately following the closure of the semilunar valves and immediately
preceding the dichotic wave, sometimes used as a marker for the end of
systole or the ejection period. As mentioned in the introduction, peripheral
pulse waveform usually has a much smaller inflection point between the main
peak and the dicrotic notch as originally shown in Figure 3. In most cases,
however, the SpO2 waveform fails to display this feature even though it can
sometimes be observed in the 1st derivative of SpO2 waveform. The PZT
pulse wave, on the other hand, shows three distinct peaks. Before the three
peaks can be clearly defined, it is necessary to more precisely compare the
PZT and SpO2 waveforms.
The contours of PZT waveform and 1st derivative of SpO2 are not quite the
same, as observed showed in Figure 11. But after inclusion of a small time
shift, it is observed that on the marked line in the time axis, the three peaks of
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Analyzing both Figure 11 and Figure 12, an advantage of PZT wave forms
over SpO2 wave forms is that the PZT wave is more sensitive to smaller
arterial pressure change and is able to capture the more important features of
peripheral pulse wave, while SpO2 wave usually misses either the dicrotic
notch or the inflection point. This alone makes PZT a more sensitive
monitoring method compared to pulse oximetry.
Another advantage of PZT over SpO2 is that PZT monitoring provides
more precise information when calculating the Heart rate variability (HRV).
The time elapsing between two consecutive R waves (the largest peaks in an
ECG measurement), more formally known as RR intervals, were extracted
from ECG, PZT and SpO2 waveforms simultaneously. The Relative Mean
Difference (RMD) of RR intervals between ECG and PZT was 0.51%, while
the RMD between ECG and SpO2 was 0.77%.This seemingly small
difference becomes significant, however, when comparing the calculated HRV.
The RMD of HRV calculated from ECG and PZT was 11.73%, while the RMD
of HRV calculated form ECG and SpO2 was 19.75%. Thus PZT monitoring
provides approximately 8% greater accuracy when calculating HRV compared
to extraction of HRV through pulse-oximetry.
4.2 PZT Pulse Wave and Respiration
Respiration is a major factor that affects the arterial blood pressure contour
when people are in a state of rest. The pressure change in the thoracic cavity
caused by the chest movement during respiration can lead to the peripheral
blood being drawn into or pushed out of lung vessels. This can cause blood
volume change in peripheral arteries and therefore change the blood pressure
contour. The relationship between respiration and PZT pulse waveform was
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p
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readily observable as the PZT signal although it does show periodicity
according to respiration.
Figure 13 is not representative of normal breathing. Instead, the breath rate
is as low as 6 breaths per minute as tested subjects were requested to take
long deep breathes. This deep breathing method provides a much larger
peripheral blood pressure change than normal breathing. The question
remained, however, whether respiration could be derived from the PZT
waveform in normal or even quick breathing patients. Unfortunately, in normal
breathing the periodicity of the PZT waveform is not as easily observed as it is
in slow, deep breathing. As a result, signal processing methods were used to
find the hidden periodic character of the PZT waveform.
As shown in Figure 13, it is the amplitude of each pulse peak that makes
the contour vary in an obvious respiration-like manor. Therefore, every major
peak of the PZT pulse waveform must be analyzed to determine the
correlation between this waveform and respiration. To accomplish this, a
concept of pulse peak strength variation was introduced. This is defined as
the amplitude variation of each pulse peak divided by the mean peak
amplitude.
An algorithm written in MATLAB code (The MathWorks, Natick, MA) was
used to extract pulse peaks from the PZT waveform. A 2nd order lowpass
digital Butterworth filter with cutoff frequency of 15 Hz was applied to reduce
the high frequency noise including electrical noise at 60 Hz. A peak detection
algorithm was then applied to the waveform. The detection algorithm used a
threshold method to find the region where the main peak of every pulse cycle
is located, including the maximum value within the region which is the pulse
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peak. The threshold should be chosen carefully to avoid either missing one of
the smaller pulse peaks or mistakenly counting one of the larger dicrotic notch
peaks. An automatic threshold selecting method was used to handle most of
the cases. This method can also be set manually to optimize the results. A
similar method was used in detecting inhalation and exhalation in the
respiration waveform.
The top and middle objects in Figure 14 show the result of pulse peak
detection during a 60-second normal breathing test. The bottom figure shows
the detection of the troughs of the respiration waveform which are the starting
points of inhalation for each respiration cycle. The respiratory rate can be
obtained directly by calculating the mean value of the intervals between
inhalation starting points, which in this case is 16.77 breaths per minute. The
pulse peak waveform shows fluctuation in a similar periodicity to the
respiration waveform. A mathematic method to extract the periodicity of pulse
peak wave was then performed to confirm the correlation between pulse peak
wave and respiration.

34

Figure
e 14, Peak Ex
xtraction from
m PZT and Respiratory
R
R
Rate Detectio
on
Figure
es based on 60
6 seconds normal
n
breath
hing test. Top: PZT pulse w
waveform; Mid
ddle: pulse
peak extraction from PZT wav
veform; Botto
om: Detection
n of the starrt point of inhalation in
respirration waveform

Co
omputing th
he difference of each
h peak poin
nt from the mean give
es us the
pulse
e peak variation show
wed in the to
op and mid
ddle figuress of Figure 15. Then
using
g Fast Fourier Transsform (FFT
T) the pow
wer spectrrum of pullse peak
varia
ation was ob
btained as the bottom figure in Figure 15 sh
hows. There
e are two
majo
or compone
ents in the
e frequencyy domain at
a 0.0167 Hz and 0.2845 Hz
respe
ectively. Comparing
C
the pulse peak varia
ation wave
eform in Figure
F
15
(midd
dle), we ca
an find the lower frequ
uency at 0.0
0167 Hz is caused by baseline
shifting of the sensor itsself, and the
t
periodic fluctuatio
on associa
ated with
respiiration is re
esponsible for the hig
gher frequency at 0.2
2845 Hz. Thus,
T
an
estim
mation of re
espiratory rate
r
is 0.28
845 Hz time
es 60 which
h compute to 17.07
breatths per minute. Comparing the actual respiratory ratte of 16.77
7 breaths

35

m
to the estimate
ed rate of 1
17.07 breatths per min
nute, corressponds to
per minute,
an errror rate of less than 2%.
2

Figure 15, Pu
ulse Peak Va
ariation and it's Power Sp
pectrum

A series of
o experiments were
e also perrformed to
o confirm that the
conn
nection betw
ween respiration and PZT pulse wave is not caused by the
slight body mov
vement thro
ough expan
nsion of chest area du
uring the re
espiration
but indeed by the intrin
nsic relationship betw
ween the cardiovascular and
respiiratory systems. Sensor locationss on the head, arm, wrist, and fin
nger were
all us
sed in thesse tests and
d the resultts showed the
t same q
quality and the error
betw
ween estim
mated resp
piratory ratte and acctual resp
piratory ratte never
exce
eeded 4%.

36

4.3 Pulse Strength at Different Head Positions
Systolic and diastolic peripheral blood pressure is most often measured in
clinical practice with the arm at the same vertical level as the heart. If a patient
raises his or her arm, the blood pressure when measured with a
sphygmomanometer will change relative to the position of the heart.
Considering that the heart is a pump, blood pressure when measured from
the raising arm should be lower since the blood must be pumped to a higher
level and more work must be done by the heart. When the arm is lowered
below the level of the heart, blood pressure will increase and the heart does
less work pumping blood to the arm. By convention, distances above the
heart are considered positive while those below are considered negative.
Given this convention, the blood pressure P given in Pascals for a given
distance h above or below the position of the heart can be determined from
Archimedes Principle,
P (Pascals) = P0 – ρgh

(1)

where P0 is the peripheral blood pressure at the heart level; ρ is the density of
blood with an average value of 1.06 g/ml and g is the gravitational constant.
The following relationship can be used to convert from Pascals to the more
conventional measurement of blood pressure expressed in millimeters of
mercury (mmHg). Given that the density of mercury is 13.6g/ml, the
conversion formula from Pascals to mmHg is given by where the distance h is
in millimeters
P(mmHg) = P0 – 1.06 · h/13.6

(2)

which simplifies to
= P0 – 0.08 ·h
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(3)

The results of this work were similar to those obtained by Guss as shown in
Table 2 [42] who determined the influence of arm position on blood pressure.
The systolic and diastolic blood pressures are lower in arm position A (the
arm is perpendicular to the torso) than in arm position B (the arm is parallel to
the torso) because the vertical level of the sphygmomanometer is higher in
position A as compared to position B.
Table 2, Blood Pressure Measurement in mmHg

Body

Arm

Systolic BP

Diastolic BP

Pulse Pressure

1

A

125.1

72.9

52.2

1

B

134.6

83.1

51.5

2

A

120.0

63.6

56.4

2

B

133.3

77.9

55.4

1 = standing; 2 = supine; A = arm perpendicular to the torso;
B = arm parallel to the torso

The response of the PZT pulse wave to peripheral blood pressure change
for different vertical positions was also examined. A test was designed to
measure blood pressure at the temporal artery with respect to several vertical
positions of the head. The results in Figure 16 show that when the vertical
position of head is higher than the heart level the PZT pulse wave has larger
amplitude, even though previous studies show that the blood pressure should
decrease when the head is at a higher level than the heart. This phenomenon
means that PZT pulse amplitude increases when the blood pressure
decreases and the amplitude decreases when the blood pressure rises.
Although the reason for this phenomenon is not known, it can be used in
predicting blood pressure change in the head caused by the Valsalva
Maneuver or vertical acceleration of the body.
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Figure 16, PZT Pulse Waveform in Different Head Positions
From top: (1): sitting up straight, vertical distance of temple over heart h is 36 cm; (2): h is 25
cm; (3) h is 15 cm; (4) supine, h is 0; (5) sitting straight up doing Valsalva maneuver

To measure the effect of head artery blood pressure change, a Valsalva
maneuver was performed with the PZT sensor placed over the temporal
artery, Figure 16 (5). With a test subject mean arterial blood pressure P0 of
90 mmHg, the data were collected and pressure computed for four different
head positions based on Equation 3 and summarized in Table 3.
Calculation of the blood pressure drop at the four head positions resulted in
mean pressures of 62, 70, 78, 90 mmHg respectively. The mean pulse peak
amplitude in PZT waveform was determined from the peak detecting
algorithm. A PZT pulse peak amplitude chart corresponding to the mean
pressure in head is shown in Figure 17. In this figure, the peak amplitude at
0.57 volts corresponds to a mean pressure of 83 mmHg. Thus, the estimated
temporal

artery

pressure

during

the
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Valsalva

maneuver

reaches

approximately 83 mmHg which suggests that the maneuver results in a 21
mmHg increase in blood pressure measured by the PZT sensor at the
location of the temporal artery.
Table 3, PZT Pulse Peak, Blood Pressure and Head Position

Head Position

Mean Pressure in Head

PZT Mean Peak

(cm)

(mmHg)

Amplitude (volt)

36

62

1.27

25

70

0.88

15

78

0.67

0

90

0.43

Valsalva maneuver with

83

0.57

head position at 36 cm

(Estimated)

Figure 17, Mean Pressure in Head and PZT Pulse Peak Amplitude
X axis: Mean blood pressure in temporal arteries at temple; Y axis: Mean pulse peak
amplitude in PZT waveform

4.4 PZT Waveform during Valsalva Maneuver
The Valsalva Maneuver (VM) is one of the most important autonomic tests
and it provides specific information about vasomotor sympathetic functions
[40]. Figure 18 shows the four phases of VM. A blood pressure increase
occurs at the beginning of Phase I because a deep breath at the beginning of
40

VM increases the intrathoracic pressure. Early Phase II represents a
decrease in blood pressure due to a reduced venous return to the heart.
Approximately

10

seconds

after

breath

holding,

the

increasing

of

noradrenergic-mediated peripheral resistance in turn increases systemic
blood pressure in the late stages of Phase II. This is the most important part
of the Valsalva maneuver since it provides a marker of peripheral resistance
mediated by sympathetic vasomotor fibers [43].

Figure 18, Intra-arterial Pressure Waveform during Valsalva Maneuver
Valsalva maneuver in a healthy subject (A) has four phases in blood pressure (B). Panel (C)
shows how to correctly determine important variables from Valsalva maneuver including the
maximal drop in the early Phase II, peak of the late Phase II (recovery) and overshoot during
the Phase IV (C) [43].

Comparing PZT pulse waveform (Figure 19) in Valsalva maneuver to
Figure 18, we can find occurrences of the different phases in the PZT pulse
waveform. As showed in Figure 17, PZT pulse peak amplitude is reversely
proportional to the mean blood pressure. At the beginning of the VM, pulse
peak suddenly decreases represents the transiently increase of blood
41

hase I. A gradual in
ncrease off the pulse
e peak am
mplitudes
presssure in Ph
corre
esponds to the pressu
ure drop wh
hich occurs at the early stage of Phase II;
while
e the gradual decrea
ase of the pulse pea
ak amplitud
des which starts at
approximately ten second
ds after th
he breath hold
h
repressents the pressure
incre
ease at the later stage
e of Phase II. Thereforre PZT pulsse waveform
m can be
used
d to effectivvely test carrdiac function and auttonomic ne
ervous control of the
heartt during Valsalva maneuver.

Figure 19, PZT Pulse W
Waveform in Valsalva Maneuver
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CHAPTER 5

Conclusions and Future work
Using a piezoelectric sensor to monitor blood pressure is a fairly new concept
given that it has only recently emerged in commercial practices. This may
partially be attributed to the fact that it cannot generate the actual pressure
waveform as intra-arterial pressure monitoring does. The use of PZT sensor
based materials can provide a similar pressure contour as other actual
pressure waveforms such as that of applanation tonometry and pulseoximetry. The PZT pulse waveform, however, indicates the change of arterial
pressure, which is similar to the 1st derivative of actual blood pressure waves.
This work showed that the small inflections including the Inflection point and
the Dicrotic notch in the intra-arterial pressure waveform are more precisely
revealed on the PZT pulse waveform versus other methods.
As a non-invasive pulse monitoring system, applanation tonometry failed to
give long term monitoring since most of the commercial devices provide a
pen-shape tonometer that must to be pressed at the radial artery at the wrist.
Any attempt to reform the tonometer to providing continuous monitoring was
deemed inconvenient and complicated. In addition, the cost of a tonometry
system can cost many thousands of dollars. Pulse-oximeter, on the other
hand, is inexpensive and easy to use. Pulse oximetry cannot provide accurate
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pressure information however, and often fails to accurately record and or
detect the pulse waveform inflection points. PZT pulse wave monitoring
compliments these two methods by providing a relatively sensitive and
accurate measurement, using a low cost and convenient finger sensor wrap.
The high correlation between respiration waves and PZT pulse waves
make PZT pulse monitoring a good method for indirectly monitoring not only
the respiratory rate but also the quality of respiration. Therefore any hazard of
apnoea or bradypnoea can be easily predicted by processing the PZT pulse
waveform. The greater response to respiration also indicates that PZT pulse
monitoring has a high sensitivity to blood volume change. This characteristic
can be used to predict the severity of hemorrhage.
As a new type of arterial pressure recording, PZT pulse waveform is still
not fully understood. Future studies on PZT pulse wave analysis may broaden
the use of PZT pulse monitoring in its ability to predict and diagnose many
other diseases associated with cardiovascular changes. Listed below are a
few examples of future work to do for better manipulating and understanding
the PZT pulse monitoring method.
(1) A pulse oximeter clip on the bottom section of finger with a PZT sensor
surrounded inside could be made. The combination of PPG and PZT
waveform will provide more detailed information about the peripheral
blood pressure and volume.
(2) A headphone-like device with PZT sensor around the ear may provide a
better result for monitoring temporal and posterior auricular arteries.
Using the correlation between pulse peak strength and mean blood
pressure, the head blood pressure change caused by body movement
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and acceleration can be estimated. This way we can have a quantitative
measurement of blood pressure change in studying the temporary
blindness of pilot during aircraft acceleration or people’s the head rush
when standing up too fast.
(3) Simulating the PZT waveform of patient suffering from hemorrhage is
highly relevant. The sensitivity to blood volume change may be used to
predict the possibility and severity of hemorrhage. It could be used as a
pre-indicator in ER for patients with the possibility of internal bleeding
before sending them to a CT scan.
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Appendix

Matlab Codes for PZT Pulse Peak Detection, Respiratory waveform
Analysis and Respiratory Rate Estimation

1. Pulse Peak Detection
clear all;
load data.mat,X;
fs=200;
X1=X(:,1);X2=X(:,3);
L=length(X1);

%---low pass filter
s=X1;
n=2; wn=15/(fs/2);
[b,a]=butter(n,wn,'low');
S0(1)=b(1)*s(1);
S0(2)=b(1)*s(2)+b(2)*s(1)-a(2)*S0(1);
for i=3:L
S0(i)=b(1)*s(i)+b(2)*s(i-1)+b(3)*s(i-2)-a(2)*S0(i-1)-a(3)*S0(i-2);
end
SS=S0(51:L);
S0=SS;
L=L-50;
S0=S0+abs(min(S0));%............
Th=max(S0)*3/5;
j=0;
for i=1:L
if S0(i)>Th
j=j+1;
QRS(j)=i;
end
end

%......may change for different signal 2/5 normal

j=0;cnt=0;
for i=2:length(QRS)
if QRS(i)-QRS(i-1)>fs/3
j=j+1;
count(j+1)=i-1-cnt;
cnt=cnt+count(j+1);
M=max( S0 (
(QRS(i-count(j+1)):QRS(i-1))
for k=(i-count(j+1)):(i-1)
if S0(QRS(k))==M
R(j)=QRS(k);
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)

);

end
end
end
end
M=max( S0 (
QRS(cnt+1):QRS(i)
for k=(cnt+1):i
if S0(QRS(k))==M
R(j+1)=QRS(k);
end
end

)

);

for i=1:length(R)
P(i)=S0(R(i));
end
Xp=S0;
t=(1:length(Xp))/200;
figure,
subplot(3,1,1),plot(t,Xp),xlabel('Time/sec'),ylabel('Amplitude'),titl
e('PZT');
subplot(3,1,2),stem(R/200,P),xlabel('Time/sec'),ylabel('Amplitude'),t
itle('Pulse Peak');
%..........
AveragePulsePeak=mean(P);
SDPP=std(P);
RelativeStandardDeriation=SDPP/mean(P)
for i=1:(length(P)-1)
Diff(i)=abs(P(i)-P(i+1));
end
%figure,plot(Diff,'.');
Differnce=sum(Diff)/i/mean(P)

2. Inhalation and exhalation extraction
%clear all
%load X_db,X;
fs=200;
X1=X(:,1);X2=X(:,3);
L=length(X2);
%---------------offset null
s=X2-mean(X2);
ss=s+max(s);
s=s/max(ss);
%s=-s;
%---------------low pass filter
n=2; wn=5/(fs/2);
[b,a]=butter(n,wn,'low');
S0(1)=b(1)*s(1);
S0(2)=b(1)*s(2)+b(2)*s(1)-a(2)*S0(1);
for i=3:L
S0(i)=b(1)*s(i)+b(2)*s(i-1)+b(3)*s(i-2)-a(2)*S0(i-1)-a(3)*S0(i-2);
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end
SS=S0(51:L);
S0=SS;
L=L-50-100; %........................................
%-------------------------------Peak Detection
S1=diff(S0);
j=0;k=0;
for i=6:L-6
if and ((abs(S1(i))<0.001),S0(i)<0) %---0.0001 variables
derivation equals zero
if and((S1(i-1)+S1(i-2)+S1(i-3)+S1(i-4)+S1(i5))<0,(S1(i+1)+S1(i+2)+S1(i+3)+S1(i+4)+S1(i+5))>0)
if and(S0(i)<S0(i+50),S0(i+50)<S0(i+100))
j=j+1;
Insp0(j)=i;
end
end
end
end
for i=length(Insp0):-1:2
if abs(Insp0(i)-Insp0(i-1))<50
100/fs=0.5 second
Insp0(i-1)=Insp0(i);
end
end
j=0;
for i=1:(length(Insp0)-1)
if Insp0(i)~=Insp0(i+1)
j=j+1;
Insp1(j)=Insp0(i);
end
end

%-----100 variables

%-----------Insp1(j+1)=Insp0(length(Insp0));
j=0;
for i=2:length(Insp1)
j=j+1;
Tb(j)=Insp1(i)-Insp1(i-1);
end
%-----------j=0;
for i=1:length(Tb);
j=j+1;
if Tb(i)<mean(Tb)/3
j=j+1;
end
if (j-1)<=length(Tb)
Insp2(i)=Insp1(j);
end
end
if j<=length(Tb)
Insp2(j+1)=Insp1(j+1);
end

%.........1/3 varibles

Insp=Insp2;
Linsp=length(Insp);
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subplot(3,1,3) ,
plot(t,(S0+abs(max(S0))));hold on,
stem(Insp2/200,ones(1,length(Insp2)));
xlabel('Time/sec'),ylabel('Amplitude'),title('Breath Waveform');
for i=1:Linsp-1
T(i)=Insp(i+1)-Insp(i);
end
ResRate=60/mean(T)*fs

3. Respiratory rate estimation
[f,pf]=psp(P-mean(P),length(P)*fs/length(S0));
for i=2:length(f)
if and (f(i)>0.12, f(i-1)<0.12)
j=i;
end
end
M=max(pf(j:length(f)));
for j=1:length(f)
if pf(j)==M
RespR=j;
end
end
EstRate=f(RespR)*60

4. PSP Function
function [f,pF] = psp(s,fs)
t=length(s);
F=fft(s,t);
pF=F.*conj(F)/t;
f=fs*(0:t/2)/t;
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